Jane Street Group, LLC Care Dx, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$28.19 - $46.6 $321,366 - $531,240	-11,400 Reduced 56.72%	8,700 $322,000
Q4 2021 Feb 15, 2022	SELL	$41.2 - $73.6 $160,680 - $287,040	-3,900 Reduced 16.25%	20,100 $914,000
Q3 2021 Nov 16, 2021	BUY	$59.15 - $91.99 $307,580 - $478,348	5,200 Added 27.66%	24,000 $1.52 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $1.78 Million - $2.69 Million	-28,300 Reduced 60.08%	18,800 $1.72 Million
Q1 2021 May 18, 2021	SELL	$57.62 - $95.6 $6.14 Million - $10.2 Million	-106,500 Reduced 69.34%	47,100 $3.21 Million
Q4 2020 Feb 17, 2021	BUY	$41.43 - $77.09 $5.56 Million - $10.3 Million	134,200 Added 691.75%	153,600 $11.1 Million
Q3 2020 Nov 17, 2020	BUY	$30.88 - $37.94 $311,888 - $383,194	10,100 Added 108.6%	19,400 $736,000
Q2 2020 Aug 17, 2020	BUY	$18.95 - $35.43 $176,235 - $329,499	9,300 New	9,300 $329,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.26B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.